What is health economic evaluation and which modelling approaches can be used to support market access activities?
In this webinar, our expert health economists explain the key strengths and limitations of the most common health economic modelling classifications and structures. Here, Hannah Gillies (Consultant – Health Economics) and Daniel MacDonald (Associate Consultant – Health Economics) de-mystify the different approaches to health economic modelling.
In this webinar, Hannah and Daniel explore the different reasons health economists may recommend a cohort- or patient-level approach for your model. Our specialists then explore six of the most common health economic modelling structures used to support market access activities;
- Decision trees
- Markov models
- Semi-Markov models
- Partitioned survival models
- Cox regression models
- Discrete event simulations
Request a copy of the presentation slides
Please complete the form below to request a copy of the slides our experts presented in this webinar.
Listen to the podcast:
This episode is also available as a podcast. Listen below or search ‘Pharma Market Access Insights – from Mtech Access’ on Spotify, Apple Podcasts or Google Podcasts.
Meet our experts
Between them, our webinar presenters have over 18 years’ experience developing health economic models for HTA, market access, and payer communications. At Mtech Access, and throughout their careers, they have worked on a broad range of disease areas for pharmaceutical, medical device, and diagnostics products.
